239 related articles for article (PubMed ID: 34486178)
21. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1.
Woodward OM; Li Y; Yu S; Greenwell P; Wodarczyk C; Boletta A; Guggino WB; Qian F
PLoS One; 2010 Aug; 5(8):e12305. PubMed ID: 20808796
[TBL] [Abstract][Full Text] [Related]
22. Polycystin-2 Mediated Calcium Signalling in the
Allan CY; Sanislav O; Fisher PR
Cells; 2024 Mar; 13(7):. PubMed ID: 38607049
[TBL] [Abstract][Full Text] [Related]
23. Polycystin-1: a master regulator of intersecting cystic pathways.
Fedeles SV; Gallagher AR; Somlo S
Trends Mol Med; 2014 May; 20(5):251-60. PubMed ID: 24491980
[TBL] [Abstract][Full Text] [Related]
24. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ma M; Legué E; Tian X; Somlo S; Liem KF
J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
[TBL] [Abstract][Full Text] [Related]
25. Calcium signaling and polycystin-2.
Anyatonwu GI; Ehrlich BE
Biochem Biophys Res Commun; 2004 Oct; 322(4):1364-73. PubMed ID: 15336985
[TBL] [Abstract][Full Text] [Related]
26. Cyst formation following disruption of intracellular calcium signaling.
Kuo IY; DesRochers TM; Kimmerling EP; Nguyen L; Ehrlich BE; Kaplan DL
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14283-8. PubMed ID: 25228769
[TBL] [Abstract][Full Text] [Related]
27. Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling.
Li Y; Wright JM; Qian F; Germino GG; Guggino WB
J Biol Chem; 2005 Dec; 280(50):41298-306. PubMed ID: 16223735
[TBL] [Abstract][Full Text] [Related]
28. Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation.
Streets AJ; Wessely O; Peters DJ; Ong AC
Hum Mol Genet; 2013 May; 22(10):1924-39. PubMed ID: 23390129
[TBL] [Abstract][Full Text] [Related]
29. Polycystin 2 regulates mitochondrial Ca
Kuo IY; Brill AL; Lemos FO; Jiang JY; Falcone JL; Kimmerling EP; Cai Y; Dong K; Kaplan DL; Wallace DP; Hofer AM; Ehrlich BE
Sci Signal; 2019 May; 12(580):. PubMed ID: 31064883
[TBL] [Abstract][Full Text] [Related]
30. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
Yanda MK; Liu Q; Cebotaru L
J Biol Chem; 2018 Jul; 293(29):11513-11526. PubMed ID: 29875161
[TBL] [Abstract][Full Text] [Related]
31. Loss of PKD1/polycystin-1 impairs lysosomal activity in a CAPN (calpain)-dependent manner.
Peintner L; Venkatraman A; Waeldin A; Hofherr A; Busch T; Voronov A; Viau A; Kuehn EW; Köttgen M; Borner C
Autophagy; 2021 Sep; 17(9):2384-2400. PubMed ID: 32967521
[TBL] [Abstract][Full Text] [Related]
32. NHA2 promotes cyst development in an in vitro model of polycystic kidney disease.
Prasad H; Dang DK; Kondapalli KC; Natarajan N; Cebotaru V; Rao R
J Physiol; 2019 Jan; 597(2):499-519. PubMed ID: 30242840
[TBL] [Abstract][Full Text] [Related]
33. Vasopressin and disruption of calcium signalling in polycystic kidney disease.
Chebib FT; Sussman CR; Wang X; Harris PC; Torres VE
Nat Rev Nephrol; 2015 Aug; 11(8):451-64. PubMed ID: 25870007
[TBL] [Abstract][Full Text] [Related]
34. Polycystin-2-dependent control of cardiomyocyte autophagy.
Criollo A; Altamirano F; Pedrozo Z; Schiattarella GG; Li DL; Rivera-Mejías P; Sotomayor-Flores C; Parra V; Villalobos E; Battiprolu PK; Jiang N; May HI; Morselli E; Somlo S; de Smedt H; Gillette TG; Lavandero S; Hill JA
J Mol Cell Cardiol; 2018 May; 118():110-121. PubMed ID: 29518398
[TBL] [Abstract][Full Text] [Related]
35. Channel Function of Polycystin-2 in the Endoplasmic Reticulum Protects against Autosomal Dominant Polycystic Kidney Disease.
Padhy B; Xie J; Wang R; Lin F; Huang CL
J Am Soc Nephrol; 2022 Aug; 33(8):1501-1516. PubMed ID: 35835458
[TBL] [Abstract][Full Text] [Related]
36. Identification of Biomarkers for PKD1 Using Urinary Exosomes.
Hogan MC; Bakeberg JL; Gainullin VG; Irazabal MV; Harmon AJ; Lieske JC; Charlesworth MC; Johnson KL; Madden BJ; Zenka RM; McCormick DJ; Sundsbak JL; Heyer CM; Torres VE; Harris PC; Ward CJ
J Am Soc Nephrol; 2015 Jul; 26(7):1661-70. PubMed ID: 25475747
[TBL] [Abstract][Full Text] [Related]
37. Inward Ca
Kleene SJ; Kleene NK
Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1165-F1173. PubMed ID: 33969696
[TBL] [Abstract][Full Text] [Related]
38. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
39. Activation of the Calcium-Sensing Receptor Corrects the Impaired Mitochondrial Energy Status Observed in Renal Polycystin-1 Knockdown Cells Modeling Autosomal Dominant Polycystic Kidney Disease.
Di Mise A; Ranieri M; Centrone M; Venneri M; Tamma G; Valenti D; Valenti G
Front Mol Biosci; 2018; 5():77. PubMed ID: 30197885
[TBL] [Abstract][Full Text] [Related]
40. Nephron-Specific Disruption of Polycystin-1 Induces Cyclooxygenase-2-Mediated Blood Pressure Reduction Independent of Cystogenesis.
Lakshmipathi J; Gao Y; Hu C; Stuart D; Genzen J; Ramkumar N; Kohan DE
J Am Soc Nephrol; 2020 Jun; 31(6):1243-1254. PubMed ID: 32300065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
